Page last updated: 2024-09-04

levofloxacin and Enterocolitis, Pseudomembranous

levofloxacin has been researched along with Enterocolitis, Pseudomembranous in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's9 (75.00)29.6817
2010's3 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Galang, MA; Gerding, DN; Hecht, DW; Johnson, S; Osmolski, JR; Sambol, SP1
Adams, DA; Donskey, CJ; Riggs, MM1
Przybylski, DJ; Reeves, DJ1
Liu, HH1
Fujii, H; Fukui, H; Ikenaka, Y; Kawaratani, H; Kin, K; Nakayama, M; Shirai, Y; Taniguchi, T; Toyohara, M; Tsujimoto, T1
Croyle, K; Harrison, LH; Krystofiak, S; Mendelsohn, AB; Muto, CA; Nouri, K; Pasculle, AW; Patel-Brown, S; Paterson, DL; Pokrywka, M; Posey, K; Roberts, T; Saul, M; Shutt, K1
Bommer, M; Döhner, H; Kern, P; Kern, WV; Marre, R; Reuter, S; Sigge, A; von Baum, H1
Dhalla, IA; Juurlink, DN; Kopp, A; Mamdani, MM; Rochon, PA; Simor, AE1
Bucaneve, G; Cullen, M; Fraser, A; Gafter-Gvili, A; Kern, WV; Leibovici, L; Paul, M1
Biller, P; Brennan, M; Killgore, G; Lind, L; McDonald, LC; Shank, B; Thompson, A; Tkatch, L1
Hassoun, A; Ibrahim, F1
Aradhyula, S; Greisnauer, S; Manian, FA; Meyer, PL; Senkel, D; Setzer, J; Wiechens, M1

Reviews

3 review(s) available for levofloxacin and Enterocolitis, Pseudomembranous

ArticleYear
Safety profile of the fluoroquinolones: focus on levofloxacin.
    Drug safety, 2010, May-01, Volume: 33, Issue:5

    Topics: Adult; Aged, 80 and over; Anti-Bacterial Agents; Cardiovascular Diseases; Central Nervous System Diseases; Child; Dermatitis, Phototoxic; Drug Hypersensitivity; Enterocolitis, Pseudomembranous; Glucose; Humans; Levofloxacin; Ofloxacin; Skin Diseases

2010
Pseudomembranous colitis complicating ulcerative colitis.
    Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society, 2010, Volume: 22, Issue:4

    Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Colitis, Ulcerative; Colonoscopy; Enterocolitis, Pseudomembranous; Female; Humans; Levofloxacin; Ofloxacin; Tomography, X-Ray Computed

2010
Antibiotic prophylaxis in neutropenic patients: new evidence, practical decisions.
    Cancer, 2006, Oct-15, Volume: 107, Issue:8

    Topics: Acute Disease; Antibiotic Prophylaxis; Antineoplastic Agents; Bone Marrow Transplantation; Ciprofloxacin; Decision Making; Drug Resistance; Enterocolitis, Pseudomembranous; Gram-Positive Bacterial Infections; Humans; Leukemia; Levofloxacin; Lymphoma; Neoplasms; Neutropenia; Ofloxacin

2006

Other Studies

9 other study(ies) available for levofloxacin and Enterocolitis, Pseudomembranous

ArticleYear
In vitro activities of 15 antimicrobial agents against 110 toxigenic clostridium difficile clinical isolates collected from 1983 to 2004.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:8

    Topics: Anti-Bacterial Agents; Bacterial Toxins; Clostridioides difficile; Drug Resistance, Bacterial; Enterocolitis, Pseudomembranous; Humans; Microbial Sensitivity Tests; United States

2007
Effect of fluoroquinolone treatment on growth of and toxin production by epidemic and nonepidemic clostridium difficile strains in the cecal contents of mice.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:8

    Topics: Anaerobiosis; Animals; Anti-Infective Agents; Bacterial Toxins; Cecum; Clostridioides difficile; Disease Models, Animal; Disease Outbreaks; Drug Resistance, Bacterial; Enterocolitis, Pseudomembranous; Fluoroquinolones; Humans; Mice; Microbial Sensitivity Tests

2007
Moxifloxacin versus levofloxacin or ciprofloxacin prophylaxis in acute myeloid leukemia patients receiving chemotherapy.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2017, Volume: 25, Issue:12

    Topics: Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Ciprofloxacin; Clostridioides difficile; Enterocolitis, Pseudomembranous; Female; Fluoroquinolones; Granulocyte Colony-Stimulating Factor; Humans; Leukemia, Myeloid, Acute; Levofloxacin; Male; Middle Aged; Moxifloxacin; Neutropenia; Randomized Controlled Trials as Topic; Retrospective Studies

2017
A large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use.
    Infection control and hospital epidemiology, 2005, Volume: 26, Issue:3

    Topics: Anti-Bacterial Agents; Case-Control Studies; Cause of Death; Clindamycin; Clostridioides difficile; Cross Infection; Diarrhea; Disease Outbreaks; Enterocolitis, Pseudomembranous; Female; Fluoroquinolones; Hospitals, Teaching; Humans; Levofloxacin; Logistic Models; Male; Ofloxacin; Pennsylvania; Retrospective Studies; Risk Factors

2005
Moxifloxacin prophylaxis in neutropenic patients.
    The Journal of antimicrobial chemotherapy, 2006, Volume: 58, Issue:4

    Topics: Anti-Infective Agents; Antibiotic Prophylaxis; Aza Compounds; Bacteremia; Clostridioides difficile; Enterocolitis, Pseudomembranous; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Levofloxacin; Moxifloxacin; Neutropenia; Ofloxacin; Quinolines

2006
Are broad-spectrum fluoroquinolones more likely to cause Clostridium difficile-associated disease?
    Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:9

    Topics: Aged; Aged, 80 and over; Aza Compounds; Case-Control Studies; Clostridioides difficile; Enterocolitis, Pseudomembranous; Female; Fluoroquinolones; Gatifloxacin; Humans; Levofloxacin; Male; Moxifloxacin; Ofloxacin; Quinolines

2006
Moxifloxacin therapy as a risk factor for Clostridium difficile-associated disease during an outbreak: attempts to control a new epidemic strain.
    Infection control and hospital epidemiology, 2007, Volume: 28, Issue:2

    Topics: Aged; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Clostridioides difficile; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Enterocolitis, Pseudomembranous; Female; Fluoroquinolones; Humans; Levofloxacin; Male; Moxifloxacin; Ofloxacin; Quinolines; Risk Factors

2007
Use of intravenous immunoglobulin for the treatment of severe Clostridium difficile colitis.
    The American journal of geriatric pharmacotherapy, 2007, Volume: 5, Issue:1

    Topics: Aged; Anti-Bacterial Agents; Carcinoma, Merkel Cell; Clostridioides difficile; Cytotoxins; Diarrhea; Ear Neoplasms; Enterocolitis, Pseudomembranous; Esomeprazole; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Levofloxacin; Male; Metronidazole; Ofloxacin; Skin Neoplasms; Thyroxine; Vancomycin

2007
Is it Clostridium difficile infection or something else? A case-control study of 352 hospitalized patients with new-onset diarrhea.
    Southern medical journal, 2007, Volume: 100, Issue:8

    Topics: Aged; Analysis of Variance; Case-Control Studies; Cefazolin; Ceftriaxone; Clostridioides difficile; Confidence Intervals; Cross Infection; Diarrhea; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Hospitalization; Humans; Incidence; Levofloxacin; Male; Missouri; Multivariate Analysis; Odds Ratio; Ofloxacin; Regression Analysis; Retrospective Studies; Risk Factors

2007